Zika virus infection confers protection against West Nile virus challenge in mice. 2017

Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
Department of Biotechnology, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Madrid 28040, Spain.

Flaviviruses are RNA viruses that constitute a worrisome threat to global human and animal health. Zika virus (ZIKV), which was initially reported to cause a mild disease, recently spread in the Americas, infecting millions of people. During this recent epidemic, ZIKV infection has been linked to serious neurological diseases and birth defects, specifically Guillain-Barrè syndrome (GBS) and microcephaly. Because information about ZIKV immunity remains scarce, we assessed the humoral response of immunocompetent mice to infection with three viral strains of diverse geographical origin (Africa, Asia and America). No infected animals showed any sign of disease or died after infection. However, specific neutralizing antibodies were elicited in all infected mice. Considering the rapid expansion of ZIKV throughout the American continent and its co-circulation with other medically relevant flaviviruses, such as West Nile virus (WNV), the induction of protective immunity between ZIKV and WNV was analyzed. Remarkably, protection after challenge with WNV was observed in mice previously infected with ZIKV, as survival rates were significantly higher than in control mice. Moreover, previous ZIKV infection enhanced the humoral immune response against WNV. These findings may be relevant in geographical areas where both ZIKV and WNV co-circulate, as well as for the future development of broad-spectrum flavivirus vaccines.

UI MeSH Term Description Entries
D007121 Immunocompetence The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. Competence, Immunologic,Immunologic Competence,Immunological Competence,Competence, Immunological
D000071243 Zika Virus Infection A viral disease transmitted by the bite of AEDES mosquitoes infected with ZIKA VIRUS. Its mild DENGUE-like symptoms include fever, rash, headaches and ARTHRALGIA. The viral infection during pregnancy, in rare cases, is associated with congenital brain and ocular abnormalities, called Congenital Zika Syndrome, including MICROCEPHALY and may also lead to GUILLAIN-BARRE SYNDROME. Congenital Zika Syndrome,Congenital Zika Virus Infection,Fever, Zika,ZikV Infection,Zika Fever,Zika Virus Disease,Disease, Zika Virus,Infection, ZikV,Infection, Zika Virus,Virus Disease, Zika,Virus Infection, Zika
D000071244 Zika Virus An arbovirus in the FLAVIVIRUS genus of the family FLAVIVIRIDAE. Originally isolated in the Zika Forest of UGANDA it has been introduced to Asia and the Americas. Virus, Zika,ZikV
D000349 Africa The continent south of EUROPE, east of the ATLANTIC OCEAN and west of the INDIAN OCEAN.
D000569 Americas The general name for NORTH AMERICA; CENTRAL AMERICA; and SOUTH AMERICA unspecified or combined. America
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D001208 Asia The largest of the continents. It was known to the Romans more specifically as what we know today as Asia Minor. The name comes from at least two possible sources: from the Assyrian asu (to rise) or from the Sanskrit usa (dawn), both with reference to its being the land of the rising sun, i.e., eastern as opposed to Europe, to the west. (From Webster's New Geographical Dictionary, 1988, p82 & Room, Brewer's Dictionary of Names, 1992, p34)
D014901 West Nile Fever A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71) Kunjin virus Infection,Encephalitis, West Nile Fever,WNV Infection,West Nile Fever Encephalitis,West Nile Fever Meningitis,West Nile Fever Meningoencephalitis,West Nile Fever Myelitis,West Nile Virus Infection,Infection, Kunjin virus,Infection, WNV,Kunjin virus Infections,WNV Infections
D014902 West Nile virus A species of FLAVIVIRUS, one of the Japanese encephalitis virus group (ENCEPHALITIS VIRUSES, JAPANESE). It can infect birds and mammals. In humans, it is seen most frequently in Africa, Asia, and Europe presenting as a silent infection or undifferentiated fever (WEST NILE FEVER). The virus appeared in North America for the first time in 1999. It is transmitted mainly by CULEX spp mosquitoes which feed primarily on birds, but it can also be carried by the Asian Tiger mosquito, AEDES albopictus, which feeds mainly on mammals. Egypt 101 virus,Kunjin virus

Related Publications

Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
March 2013, Journal of virology,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
January 2024, The Journal of infectious diseases,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
January 2021, Frontiers in immunology,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
March 2018, Vaccine,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
April 2019, Journal of virology,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
November 2019, Trends in neurosciences,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
January 2012, PloS one,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
August 2011, Immunology letters,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
January 2020, NPJ vaccines,
Ángela Vázquez-Calvo, and Ana-Belén Blázquez, and Estela Escribano-Romero, and Teresa Merino-Ramos, and Juan-Carlos Saiz, and Miguel A Martín-Acebes, and Nereida Jiménez de Oya
December 2003, The Journal of experimental medicine,
Copied contents to your clipboard!